Page last updated: 2024-11-02

1,7-dimethylxanthine and Atherosclerotic Parkinsonism

1,7-dimethylxanthine has been researched along with Atherosclerotic Parkinsonism in 1 studies

1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, K1
Xu, YH1
Chen, JF1
Schwarzschild, MA1

Other Studies

1 other study available for 1,7-dimethylxanthine and Atherosclerotic Parkinsonism

ArticleYear
Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease.
    Neuroscience, 2010, May-05, Volume: 167, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Caffeine; Corpus Striatum; Dopamine; Male; Mi

2010